University Hospital Zurich, Division of Thoracic Surgery
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Opitz, Isabelle
ADOPT-lung, NCT06284317: A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients with Early-stage, Operable, Non-small Cell Lung Cancer.

Recruiting
3
290
Europe, RoW
Adjuvant durvalumab
ETOP IBCSG Partners Foundation, AstraZeneca AG Switzerland
Non Small Cell Lung Cancer
10/29
03/30
SINCERE, NCT04537182: Surgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema

Recruiting
N/A
120
Europe
Lung volume reduction surgery, LVRS, Bronchoscopic lung volume reduction with valves, BLVR
Isabelle Opitz, Professor, MD
Emphysema
03/28
03/28
Gambazzi, Franco
SINCERE, NCT04537182: Surgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema

Recruiting
N/A
120
Europe
Lung volume reduction surgery, LVRS, Bronchoscopic lung volume reduction with valves, BLVR
Isabelle Opitz, Professor, MD
Emphysema
03/28
03/28

Download Options